Painful spondylolysis or spondylolisthesis studied by radiography and single-photon emission computed tomography.

Spondylolysis: a critical review. Br J Sports Med (2000) 1.39

Juvenile spondylolysis: a comparative analysis of CT, SPECT and MRI. Skeletal Radiol (2004) 1.22

Lumbar spondylolysis: a review. Skeletal Radiol (2010) 1.08

L5 spondylolysis/spondylolisthesis: a comprehensive review with an anatomic focus. Childs Nerv Syst (2012) 0.94

The value of combining single photon emission computerised tomography and computerised tomography in the investigation of spondylolysis. Eur Spine J (2004) 0.90

The value of SPECT in the detection of stress injury to the pars interarticularis in patients with low back pain. J Orthop Surg Res (2010) 0.90

Comparing spondylolysis in cricketers and soccer players. Br J Sports Med (2004) 0.85

Single photon emission computed tomography (SPECT) scanning for adolescent back pain. A sine qua non? Br J Sports Med (1994) 0.80

Spondylolysis in young tennis players. Br J Sports Med (2006) 0.79

The diagnosis and prognosis of impingement syndrome in the shoulder with using quantitative SPECT assessment: a prospective study of 73 patients and 24 volunteers. Clin Orthop Surg (2009) 0.77

Low Back Pain in Athletes. Asian J Sports Med (2015) 0.76

Disc space-targeted angled axial MR images of the lumbar spine: a potential source of diagnostic error. Skeletal Radiol (2007) 0.76

Traumatic spondylolysis in a heptathlete: a case history and review. J Chiropr Med (2005) 0.75

The 100 most cited papers in spinal deformity surgery: a bibliometric analysis. Orthop Rev (Pavia) (2014) 0.75

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81

Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol (1999) 6.66

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med (1997) 6.13

Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol (1997) 3.93

Carpal dislocations: pathomechanics and progressive perilunar instability. J Hand Surg Am (1980) 3.89

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.74

Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J Immunol (1998) 3.65

Seat belt usage: A potential target for applied behavior analysis. J Appl Behav Anal (1980) 3.59

Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology (1994) 3.18

A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10

Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol (1998) 2.94

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J Virol (1996) 2.85

Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med (1994) 2.81

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med (1999) 2.77

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med (1994) 2.72

Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol (1999) 2.65

Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis (1996) 2.56

Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity (2000) 2.53

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol (1996) 2.51

Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. AJR Am J Roentgenol (1995) 2.43

The form and function of the sieve tube: a problem in reconciliation. Int Rev Cytol (1968) 2.26

Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.15

Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol (1996) 2.07

Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol (1998) 1.94

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol (1998) 1.92

Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci U S A (1998) 1.88

An animal model for acute and persistent Epstein-Barr virus infection. Science (1997) 1.85

Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol (1987) 1.81

"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. I. Clinical aspects. Arthritis Rheum (1981) 1.79

Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc (1985) 1.77

Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. Clin Immunol Immunopathol (1997) 1.74

Detection of 16 gamma-ray pulsars through blind frequency searches using the Fermi LAT. Science (2009) 1.74

Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli. Infect Immun (2000) 1.59

Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV. J Virol (1998) 1.59

Epicuticular wax in the stomatal antechamber of sitka spruce and its effects on the diffusion of water vapour and carbon dioxide. Planta (1971) 1.56

Persistence of Escherichia coli O157:H7 in dairy cattle and the dairy farm environment. Epidemiol Infect (1997) 1.51

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47

Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood (2001) 1.43

The acutely injured wrist and its residuals. Clin Orthop Relat Res (1980) 1.43

Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J Virol (2000) 1.43

Isolated muscular sarcoidosis causing fever of unknown origin: the value of gallium-67 imaging. J Nucl Med (1991) 1.43

Iodine-131 contamination from thyroid cancer patients. J Nucl Med (1992) 1.42

T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J Exp Med (1996) 1.42

Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. JAMA (1986) 1.41

The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. J Neurosurg (1993) 1.40

Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med (1998) 1.39

Development of a Head Scanner for Proton CT. Nucl Instrum Methods Phys Res A (2012) 1.39

Stress fracture of the tibia following extensive hindfoot and ankle arthrodesis: a report of three cases. Foot Ankle Int (1995) 1.39

Acronym for dual-energy x-ray absorptiometry. Radiology (1990) 1.39

The Fermi Gamma-Ray Space Telescope discovers the pulsar in the young galactic supernova remnant CTA 1. Science (2008) 1.39

Treatment of tumors of the brain. Wis Med J (1996) 1.39

Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells. Proc Natl Acad Sci U S A (1997) 1.38

Bone scintigraphy in the reflex sympathetic dystrophy syndrome. Radiology (1981) 1.38

Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37

Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. Eur J Immunol (2000) 1.35

Addicted physicians. A closer look. JAMA (1981) 1.34

Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J Immunol (1993) 1.32

Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques. J Virol (1996) 1.31

Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol (1992) 1.31

Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis (1995) 1.30

Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. J Virol (1999) 1.28

Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection. J Virol (2001) 1.27

Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J Virol (1999) 1.27

Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus. J Virol (2000) 1.25

Escherichia coli O157:H7 diarrhoea associated with well water and infected cattle on an Ontario farm. Epidemiol Infect (1998) 1.24

Live attenuated AIDS vaccines: hazards and hopes. Nat Med (1999) 1.24

A population of gamma-ray millisecond pulsars seen with the Fermi Large Area Telescope. Science (2009) 1.24

Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Proc Natl Acad Sci U S A (1999) 1.23

Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell Immunol (2008) 1.23

Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J Clin Invest (1997) 1.21

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens. J Virol (1993) 1.20

A limit on the variation of the speed of light arising from quantum gravity effects. Nature (2009) 1.20

Identification of regions affecting virulence, RNA processing and infectivity in the virulent satellite of turnip crinkle virus. EMBO J (1988) 1.19

Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18

Estrogen-receptor protein in intracranial meningiomas. J Neurosurg (1979) 1.18

Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol (2000) 1.17

Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur J Immunol (2001) 1.17

An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. J Immunol (1995) 1.17

HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res Hum Retroviruses (1994) 1.15

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis (1996) 1.15

Capsular polysaccharide antigens for detection of serotype-specific antibodies to Actinobacillus pleuropneumoniae. Can J Vet Res (1990) 1.12

Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J Virol (1997) 1.12

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions. J Virol (2000) 1.11

Stress incontinence in the Black female. S Afr Med J (1975) 1.11

The conduction of sap : II. Detection of vibrations produced by sap cavitation in Ricinus xylem. Planta (1966) 1.09

Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1. Infect Immun (1992) 1.09

Listeroisis in immunosuppressed patients. A cluster of eight cases. Am J Med (1975) 1.08

Olecranon fractures treated with AO screw and tension bands. Orthopedics (1986) 1.07

Chronic knee pain assessed by SPECT: comparison with other modalities. Radiology (1985) 1.07

Bone SPECT. Semin Nucl Med (1987) 1.07